Dr. Daniel Von Hoff Chosen As 2015 Researcher of the Year By AZ Business Magazine

Dr. Daniel Von Hoff Chosen As 2015 Researcher of the Year By AZ Business Magazine

April 10, 2015

AZ Business Magazine which is celebrating its “30 Years of Excellence” recognized Dr. Daniel Von Hoff as its “2015 Medical Researcher of The Year” at its Healthcare Leadership Awards Dinner on April 9, 2015. Dr. Von Hoff, Translational Genomics Research Institute’s (TGen) Distinguished Professor and Physician-In-Chief directs clinical trials at the Virginia G. Piper Cancer Center in Scottsdale, Arizona.

“I am honored to be named AZ Business magazine’s Researcher of the Year, especially in light of the other fine physician-scientists nominated,” said Dr. Von Hoff. “Our work in translation of laboratory discoveries into clinical trials is vitally important for the many patients who we all strive to help.”

Many of his colleagues consider Dr. Von Hoff one of the world’s foremost oncologist, medical researcher and cancer scientist. Renowned for his pancreatic cancer research and involvement in the development of more than a half-dozen revolutionary drugs that have extended lives of countless pancreatic cancer patients. He has led or been an instrumental participant on more than 200 clinical trials during his career.

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).

Among Dr. Von Hoff’s Many Awards

Joshua Lederberg Society
Scripps Genomic Medicine Award
American Society of Clinical Oncology Award

Related Information

TGen Study: Destroying Material That Cloaks Cancer Cells
Napoli-1-Phase 3 Clinical Trial
Abraxane Acts Like A Trojan Horse
Dr. Daniel Von Hoff: Trailblazer